Job creations
The Information Technology & Innovation Foundation recently published a report diving into the U.S.’s trade deficits in the life sciences industry worldwide and steps that can be made to keep the biopharma and medical device industries competitive globally.
As Biogen turns 40 years old, some biotech insiders and analysts seem to be concerned that the Boston-based pharmaceutical company has too many eggs in one developmental basket.
Pfizer launched a new ad that celebrates diversity in its employment.
The San Francisco Business Times and the Silicon Valley Business Journal pulled together to create a list of the Best Places to Work in the Bay Area. Hitting the list at number 23 for large companies is biotechnology company Amyris.
About two years ago, former president and chief executive officer of Sarepta Therapeutics, Chris Garabedian, formed Xontogeny, a biotech accelerator. Xontogeny was founded to support life science technology startups.
With the cutting of a ribbon more than 200 new jobs are expected to be created as China-based WuXi AppTec officially opened its expanded Laboratory Testing Division (LTD) facility in New Jersey.
The people at Eloxx Pharmaceuticals share a common goal — to bring safe and effective therapies to children and adults suffering from rare genetic diseases as quickly as possible.
Healthcare companies are now looking at pharma executives for leadership roles as the landscape of healthcare is dramatically changing.
Gene-editing company Inscripta, formerly known as Muse Biotechnologies, will be able to expand its research capabilities and increase hiring after the company closed a Series C funding round of $55.5 million.
Medical device firm Caisson Interventional LLC plans to expand its Maple Grove facilities by 30,000 square foot and add 50 jobs.
PRESS RELEASES